Isosorbide mononitrate/arginine - Angiogenix

Drug Profile

Isosorbide mononitrate/arginine - Angiogenix

Alternative Names: ACCLAIM

Latest Information Update: 24 Jun 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Angiogenix Inc
  • Class Basic amino acids; Diamino amino acids; Essential amino acids; Ischaemic heart disorder therapies; Organic nitrates; Sugar alcohols; Vasodilators
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Angina pectoris

Most Recent Events

  • 08 Feb 2005 Data from a media release have been added to the Ischaemic Heart Disease therapeutic trials section
  • 31 Jan 2005 Angiogenix has completed a phase II trial in chronic angina pectoris in 7 countries
  • 29 Jun 2004 Nitrate/arginine is available for licensing (
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top